Literature DB >> 3920098

Glycosylation of human fibrinogen in vivo.

A Lütjens, A A te Velde, E A vd Veen, J vd Meer.   

Abstract

Fibrinogen was purified from plasma from 22 non-diabetic and 26 poorly controlled Type 1 (insulin-dependent) diabetic subjects. In non-diabetic subjects, 0.95 +/- 0.17 mol glucose was bound per mol fibrinogen, whereas in the diabetic subjects 1.33 +/- 0.21 mol glucose was bound per mol fibrinogen (mean +/- SD, p less than 0.001). Comparison of the amount of bound glucose, when estimated by two different methods, suggested that lysine is the site of glycosylation. It is currently unknown whether this increased glycosylation of fibrinogen alters its function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3920098     DOI: 10.1007/bf00279921

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  7 in total

1.  In vitro synthesis of hemoglobin AIc.

Authors:  R Flückiger; K H Winterhalter
Journal:  FEBS Lett       Date:  1976-12-01       Impact factor: 4.124

2.  [A SCREENING-TEST, FOLLOWED BY A RAPID QUANTITATIVE MICRODETERMINATION OF PLASMA FIBRINOGEN].

Authors:  T STRENGERS; E G ASBERG
Journal:  Ned Tijdschr Geneeskd       Date:  1963-11-02

3.  Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasmin.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Diabetes       Date:  1983-07       Impact factor: 9.461

Review 4.  Protein modification by non-enzymatic glucosylation: possible role in the development of diabetic complications.

Authors:  O H Wieland
Journal:  Mol Cell Endocrinol       Date:  1983-02       Impact factor: 4.102

5.  The preparation and properties of human fibrinogen of relatively high solubility.

Authors:  M W Mosesson; S Sherry
Journal:  Biochemistry       Date:  1966-09       Impact factor: 3.162

6.  Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins.

Authors:  E Schleicher; O H Wieland
Journal:  J Clin Chem Clin Biochem       Date:  1981-02

7.  Structure of carbohydrate of hemoglobin AIc.

Authors:  R J Koenig; S H Blobstein; A Cerami
Journal:  J Biol Chem       Date:  1977-05-10       Impact factor: 5.157

  7 in total
  8 in total

1.  The influence of type 2 diabetes on fibrin structure and function.

Authors:  E J Dunn; R A S Ariëns; P J Grant
Journal:  Diabetologia       Date:  2005-04-29       Impact factor: 10.122

2.  Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Authors:  M M Landgraf-Leurs; T Ladik; B Smolka; T Bock; W Schramm; M Spannagl; R Landgraf
Journal:  Klin Wochenschr       Date:  1987-07-01

Review 3.  [The significance of the Maillard reaction in human physiology].

Authors:  E Schleicher
Journal:  Z Ernahrungswiss       Date:  1991-02

4.  Polymerisation and crosslinking of fibrin monomers in diabetes mellitus.

Authors:  A Lütjens; T W Jonkhoff-Slok; C Sandkuijl; E A vd Veen; J vd Meer
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

5.  High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.

Authors:  Sara Tehrani; Aleksandra Antovic; Fariborz Mobarrez; Koteiba Mageed; Per-Eric Lins; Ulf Adamson; Håkan N Wallén; Gun Jörneskog
Journal:  Diabetes Care       Date:  2011-12-06       Impact factor: 19.112

Review 6.  Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.

Authors:  Katherine Kearney; Darren Tomlinson; Kerrie Smith; Ramzi Ajjan
Journal:  Cardiovasc Diabetol       Date:  2017-03-09       Impact factor: 9.951

7.  Glucose Concentration Affects Fibrin Clot Structure and Morphology as Evidenced by Fluorescence Imaging and Molecular Simulations.

Authors:  Jacob E Hood; Sumith Yesudasan; Rodney D Averett
Journal:  Clin Appl Thromb Hemost       Date:  2018-08-16       Impact factor: 2.389

8.  Fibrinogen Glycation and Presence of Glucose Impair Fibrin Polymerization-An In Vitro Study of Isolated Fibrinogen and Plasma from Patients with Diabetes Mellitus.

Authors:  Boguslawa Luzak; Magdalena Boncler; Marcin Kosmalski; Ewelina Mnich; Lidia Stanczyk; Tomasz Przygodzki; Cezary Watala
Journal:  Biomolecules       Date:  2020-06-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.